Wells Fargo & Company Neogenomics Inc Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Neogenomics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 84,391 shares of NEO stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,391

Previous 78,336 7.73%

Holding current value

$1.16 Million

Previous $1.16 Million 20.35%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$13.0 - $18.43 $78,715 - $111,593	6,055 Added 7.73%	84,391 $1.39 Million
Q3 2024 Nov 13, 2024	BUY	$13.4 - $17.73 $20,703 - $27,392	1,545 Added 2.01%	78,336 $1.16 Million
Q2 2024 Aug 13, 2024	BUY	$13.01 - $15.77 $40,500 - $49,092	3,113 Added 4.23%	76,791 $1.07 Million
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $228,053 - $272,333	16,220 Added 28.23%	73,678 $1.16 Million
Q4 2023 Feb 09, 2024	SELL	$11.67 - $20.73 $118,660 - $210,782	-10,168 Reduced 15.04%	57,458 $929,000
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $55,950 - $82,199	-4,605 Reduced 6.38%	67,626 $831,000
Q2 2023 Aug 15, 2023	BUY	$14.1 - $19.83 $399,735 - $562,180	28,350 Added 64.61%	72,231 $1.16 Million
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $227,013 - $485,744	24,974 Added 132.09%	43,881 $763,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $22,607 - $42,305	-3,505 Reduced 15.64%	18,907 $174,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $90,924 - $149,342	-11,568 Reduced 34.04%	22,412 $193,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $479,345 - $948,507	-67,896 Reduced 66.65%	33,980 $277,000
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $1.6 Million - $4.66 Million	-131,995 Reduced 56.44%	101,876 $1.24 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $17.9 Million - $28.5 Million	-587,983 Reduced 71.54%	233,871 $7.98 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $1.53 Million - $1.92 Million	36,615 Added 4.66%	821,854 $39.6 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $3.06 Million - $4.32 Million	-83,568 Reduced 9.62%	785,239 $35.5 Million
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $2.88 Million - $4.14 Million	-69,193 Reduced 7.38%	868,807 $41.9 Million
Q4 2020 Feb 09, 2021	SELL	$36.08 - $56.47 $686,602 - $1.07 Million	-19,030 Reduced 1.99%	938,000 $50.5 Million
Q3 2020 Nov 05, 2020	BUY	$33.26 - $40.48 $1.99 Million - $2.43 Million	59,960 Added 6.68%	957,030 $35.3 Million
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $1.74 Million - $2.22 Million	-71,697 Reduced 7.4%	897,070 $27.8 Million
Q1 2020 May 14, 2020	BUY	$20.5 - $34.53 $19.9 Million - $33.5 Million	968,767 New	968,767 $26.7 Million

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

116K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.73B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Neogenomics Inc Transaction History